9 results about "AIDS disorders" patented technology

Subject matter of the present invention is an angiotensin-receptor-agonist and / or a precursor thereof for use in the treatment of a disease in a subject, • wherein said disease is selected from the group comprising heart failure, chronic heart failure, acute heart failure (AHF), myocardial infarction (MI), stroke, liver failure, burn injuries, traumatic injuries, severe infection (microbial, viral (e.g. AIDS), parasitic diseases (e.g. Malaria)), SIRS or sepsis, cancer, acute kidney injury (AKI), CNS disorders (e.g. seizures, neurodegenerative diseases), autoimmune diseases, vascular diseases, hypotension and shock, and • wherein said subject has an amount of DPP3 protein and / or DPP3 activity in a sample of bodily fluid that is above a predetermined threshold.

The invention relates to an exemption treatment system for an AIDS patient, and the system comprises a patient information input module which is used for inputting basic information of the patient; the patient evaluation module is used for evaluating psychological, physical and social indexes of the patient according to the input information; the providing and processing module for formulating or adjusting a patient treatment scheme is connected with the patient evaluation module; and the AIDS patient intervention rehabilitation processing module is connected with the processing module for formulating or adjusting the patient psychological treatment scheme. The invention further relates to a corresponding method and device, a processor and a storage medium thereof. By adopting the system, the method and the device for the exemption treatment system evaluation and rehabilitation management for the AIDS patient, the processor and the storage medium thereof, an individualized, intelligent and convenient psychological treatment scheme is formulated and provided for the AIDS patient; therefore, psychological-physiological-social rehabilitation of AIDS patients can be realized to the greatest extent.

Provided herein are specific doses of, and dosing regimens for, using a HIF prolyl hydroxylase inhibitor in treating or preventing anemia, such as anemia secondary to or associated with chronic kidney disease, anemia associated with or resulting from chemotherapy, or anemia associated with AIDS.

Described herein are methods, compositions, products, and processes that utilize bioceramics in traditional agricultural and hydroponic systems. The bioceramics are utilized in powder form, as films, as aerosols, as water based treatment systems, or in solid forms. The methods and bioceramic compositions described here are also used for growing a Cannabis plant. One or more cannabinoids within the plant can be used in therapeutic compositions for the treatment of glaucoma, AIDS wasting syndrome, neuropathic pain, cancer, multiple sclerosis, chemotherapy-induced nausea, and certain seizure disorders.

The invention provides a traditional Chinese medicine composition for treating spleen-kidney yang deficiency type acquired immune deficiency syndrome related diarrhea and application, and belongs to the technical field of traditional Chinese medicine. The traditional Chinese medicine composition comprises the following components in parts by mass: 10-20 parts of common fenugreek seed, 4-8 parts of baked ginger, 5-15 parts of codonopsis pilosula, 4-8 parts of divaricate saposhnikovia root, 2-8 parts of elecampane, 2-6 parts of coptis chinensis, 4-8 parts of roasted rhizoma atractylodis macrocephalae, 2-8 parts of raw liquorice, 5-15 parts of nutmeg, 10-20 parts of salted semen plantaginis, 5-15 parts of scorched hawthorn fruit, 2-8 parts of honey-fried liquorice and 10-20 parts of dandelion. According to the traditional Chinese medicine composition, the content of inflammatory factors in intestinal flora and serum is adjusted, and the symptoms of spleen-kidney yang deficiency type AIDS related diarrhea patients can be remarkably improved.

The present invention relates to methods for evaluating and / or predicting the outcome of a clinical condition, such as cancer, metastasis, AIDS, autism, Alzheimer's, and / or Parkinson's disorder. The methods can also be used to monitor and track changes in a patient's DNA and / or RNA during and following a clinical treatment regime. The methods may also be used to evaluate protein and / or metabolite levels that correlate with such clinical conditions. The methods are also of use to ascertain the probability outcome for a patient's particular prognosis.

The invention relates to the technical field of computers, discloses an internet-of-things-driven AIDS patient remote follow-up monitoring method and system, and aims to solve the problems that in the prior art, multi-source data fusion is insufficient, risk prediction precision is low, a model lacks self-adaptive ability, and intervention is disjointed from clinic. The method comprises the following steps: collecting physiological, medication and environmental data in real time through an Internet of Things terminal; cleaning, alignment and feature extraction are carried out through an edge gateway; the method comprises the following steps: fusing an electronic medical record at a cloud end, performing dynamic modeling by utilizing a hybrid model of a time sequence convolutional network and a long-short-term memory network, and generating an individualized health risk score through a cross-modal attention mechanism; and matching the three-level intervention rule base based on the score, and dynamically pushing follow-up or medical instructions. According to the technical scheme, high-precision risk early warning, minute-level continuous monitoring, low-delay response and personalized closed-loop intervention can be achieved, and the follow-up compliance rate and the clinical intervention efficiency are remarkably improved.

The application provides a traditional Chinese medicine composition for treating AIDS combined with pneumocystis pneumonia, and belongs to the technical field of traditional Chinese medicines.The traditional Chinese medicine composition is prepared from the following raw medicinal materials in a proportion by weight: lily 10-16 parts, raw rehmannia 5-12 parts, prepared rehmannia 5-12 parts, ophiopogon 5-12 parts, licorice 2-6 parts, fried white peony root 2-6 parts, scrophularia 5-12 parts, platycodon 2-6 parts, angelica 5-12 parts, radix pseudostellariae 10-16 parts, astragalus 10-16 parts, and atractylodes 10-16 parts.It has been verified that the traditional Chinese medicine composition can obviously improve the effective treatment rate; when treating patients with AIDS combined with pneumocystis pneumonia, in addition to the conventional application of compound sulfamethoxazole (SMZ-TMP) and / or combined with lily solid gold soup oral treatment, the application of SMZ-TMP combined with the traditional Chinese medicine composition can effectively improve the symptoms, chest CT performance and other conditions of the patients, and can shorten the time of the uncomfortable symptoms of the patients.